Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Concomitant Occurrence of Polyclonal Hematopoiesis and Cell-Autonomous Megakaryopoiesis in Triple-Negative Essential Thrombocythemia

Tadaaki Inano, MDPhD, Marito Araki, PhD, Soji Morishita, PhD, Misa Imai, PhD, Yoshihiko Kihara, Maho Okuda, PhD, Masafumi Ito, MD PhD, Satoshi Osaga, Yinjie Yang, PhD, Yoko Edahiro, MD PhD, Tomonori Ochiai, MDPhD, Kyohei Misawa, MDPhD, Yasutaka Fukuda, MDPhD, Akimichi Ohsaka, MD PhD, Norio Komatsu, MD PhD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-134494

Published: 2020

Journal Articles

CREB3L1 Overexpression Can Reliably Discriminate Ph-MPNs from Reactive Cases

Soji Morishita, PhD, Hajime Yasuda, MD PhD, Saya Yamawaki, Hideya Kawaji, PhD, Masayoshi Itoh, PhD, Yoko Edahiro, MD PhD, Misa Imai, PhD, Yasushi Kogo, PhD, Satoshi Tsuneda, PhD, Akimichi Ohsaka, MD PhD, Yoshihide Hayashizaki, MD PhD, Marito Araki, PhD, Norio Komatsu, MD PhD

Blood (2020) 136 (Supplement 1): 41.

https://doi.org/10.1182/blood-2020-137325

Published: 2020

Journal Articles

MPL Overexpression Induces a High Level of Mutant-Calr/MPL Complex: A Novel Mechanism of Ruxolitinib Resistance in Myeloproliferative Neoplasms with Calr Mutations

Shunichiro Yasuda, MD, Satoru Aoyama, MD, Ryoto Yoshimoto, Student, Daisuke Watanabe, MD, PhD, Hiroki Akiyama, MD, PhD, Kouhei Yamamoto, Takeo Fujiwara, MD, Emiko Sakaida, MDPhD, Yoko Edahiro, MD PhD, Misa Imai, PhD, Marito Araki, PhD, Norio Komatsu, MD PhD, Norihiko Kawamata, MD, PhD

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-139162

Published: 2020

Journal Articles

Overexpression of MPL Causes Ruxolitinib-Resistance in Myeloproliferative Neoplasms with Calreticulin Frame-Shift Mutations

Shunichiro Yasuda, MD, Satoru Aoyama, MD, Ryoto Yoshimoto, Student, Watanabe Daisuke, MD, Hiroki Akiyama, MD, PhD, Yoshihiro Umezawa, MD, PhD, Ayako Nogami, MD PhD BPharm, Kouhei Yamamoto, Takeo Fujiwara, MD, Yoko Edahiro, MD PhD, Marito Araki, PhD, Norio Komatsu, MD PhD, Tetsuya Fukuda, MD PhD, Ayako Arai, MD PhD, Osamu Miura, MD, PhD, Norihiko Kawamata

Blood (2019) 134 (Supplement_1): 1690.

https://doi.org/10.1182/blood-2019-122652

Published: 2019

Journal Articles

The Zygosity of JAK2 V617F Determines the Disease Entities of Myeloproliferative Neoplasms By Modulating Erythropoiesis but Not Megakaryopoiesis

Hiraku Takei, MS, Yoko Edahiro, MD PhD, Lihua Li, PhD, Yoshihisa Mizukami, PhD, Misa Imai, PhD, Soji Morishita, PhD, Akimichi Ohsaka, MD PhD, Marito Araki, PhD, Norio Komatsu, MD PhD

Blood (2018) 132 (Supplement 1): 3068.

https://doi.org/10.1182/blood-2018-99-112419

Published: 2018

Journal Articles

Secreted Mutant Calreticulins As Rogue Cytokines Trigger Thrombopoietin Receptor Activation Specifically in CALR Mutated Cells: Perspectives for MPN Therapy

Blood (2018) 132 (Supplement 1): 4.

https://doi.org/10.1182/blood-2018-99-118348

Published: 2018

Journal Articles

Activation of AP-1 By JAK2V617F through Induction and Stabilization of c-FOS

Yoko Edahiro, MD PhD, Marito Araki, PhD, Yumi Hironaka, Yinjie Yang, PhD, Soji Morishita, PhD, Yoshitaka Sunami, MD PhD, Akimichi Ohsaka, MD PhD, Norio Komatsu, MD PhD

Blood (2015) 126 (23): 4098.

https://doi.org/10.1182/blood.V126.23.4098.4098

Published: 2015

NARROW

Concomitant Occurrence of Polyclonal Hematopoiesis and Cell-Autonomous Megakaryopoiesis in Triple-Negative Essential Thrombocythemia

CREB3L1 Overexpression Can Reliably Discriminate Ph-MPNs from Reactive Cases

MPL Overexpression Induces a High Level of Mutant-Calr/MPL Complex: A Novel Mechanism of Ruxolitinib Resistance in Myeloproliferative Neoplasms with Calr Mutations

Overexpression of MPL Causes Ruxolitinib-Resistance in Myeloproliferative Neoplasms with Calreticulin Frame-Shift Mutations

The Zygosity of JAK2 V617F Determines the Disease Entities of Myeloproliferative Neoplasms By Modulating Erythropoiesis but Not Megakaryopoiesis

Secreted Mutant Calreticulins As Rogue Cytokines Trigger Thrombopoietin Receptor Activation Specifically in CALR Mutated Cells: Perspectives for MPN Therapy

Activation of AP-1 By JAK2V617F through Induction and Stabilization of c-FOS

Email alerts

ASH Publications

American Society of Hematology

Concomitant Occurrence of Polyclonal Hematopoiesis and Cell-Autonomous Megakaryopoiesis in Triple-Negative Essential Thrombocythemia

CREB3L1 Overexpression Can Reliably Discriminate Ph-MPNs from Reactive Cases

MPL Overexpression Induces a High Level of Mutant-Calr/MPL Complex: A Novel Mechanism of Ruxolitinib Resistance in Myeloproliferative Neoplasms with Calr Mutations

Overexpression of MPL Causes Ruxolitinib-Resistance in Myeloproliferative Neoplasms with Calreticulin Frame-Shift Mutations

The Zygosity of JAK2 V617F Determines the Disease Entities of Myeloproliferative Neoplasms By Modulating Erythropoiesis but Not Megakaryopoiesis

Secreted Mutant Calreticulins As Rogue Cytokines Trigger Thrombopoietin Receptor Activation Specifically in CALR Mutated Cells: Perspectives for MPN Therapy

Activation of AP-1 By JAK2V617F through Induction and Stabilization of c-FOS

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only